Read + Share
Zheng MM, Li YS, Sun H, Wu YL, et al. Osimertinib Leads the Way Toward Improving Outcomes of EGFR-Mutant NSCLC With
Leptomeningeal Metastases. J Thorac Oncol 2021;16:e12-e14.
PMID: 33494928
|
 |
|
Zheng MM, Li YS, Sun H, Wu YL, et al. Osimertinib Leads the Way Toward Improving Outcomes of EGFR-Mutant NSCLC With
Leptomeningeal Metastases. J Thorac Oncol 2021;16:e12-e14.
PMID: 33494928
|
|
|
|